Sysmex Corporation (SSMXY) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Kobe, 日本. 現CEOは Hisashi Ietsugu.
SSMXY を有する IPO日 2011-10-17, 10,042 名の正社員, に上場 Other OTC, 時価総額 $5.5B.
Sysmex Corporation is a Japanese diagnostic instrument manufacturer headquartered in Kobe that develops, manufactures, and sells hematology analyzers, immunochemistry systems, flow cytometers, and related reagents and software globally. The company's product portfolio includes white blood cell differentiation instruments, urine analysis systems, infectious disease and tumor marker assays, cancer diagnostic systems, and digital medicine platforms, serving hospitals, research institutions, and medical centers across approximately 190 countries. Beyond diagnostic instruments, Sysmex provides laboratory information system software, facility management services, nucleic acid analogs, IT solutions, and medical robotics, with a strategic alliance with QIAGEN for cancer companion diagnostics development. Founded in 1968, the company has established itself as a comprehensive in vitro diagnostics provider serving both public and private healthcare institutions worldwide.
